Robotic magnetic navigation (RMN)-guided catheter ablation (CA) technology has been effectively used for nearly 20 years in treating heart rhythm disorders, showing benefits like greater catheter stability and safety.
This consensus paper aims to compile current knowledge and offer guidelines on utilizing RMN-guided CA for conditions like atrial fibrillation (AF) and ventricular arrhythmias (VA).
The expert group reviewed literature and shared experiences to create a structured set of recommendations, addressing practical aspects of RMN use in clinical settings for optimal patient care.
The study investigates the impact of atrial fibrillation (AF) on symptoms and health-related quality of life (HRQoL) among a large group of patients in Scandinavia, focusing on gender and age differences.
Results show women report more symptoms and have a greater negative impact on HRQoL, while older patients mainly experienced more negative influences in specific areas.
The findings highlight the importance of considering gender-related differences in care and management of AF, emphasizing the need for gender-specific patient-reported outcomes measures.
Cardiac resynchronization therapy can help stabilize patients who have severe heart failure while they wait for a heart transplant.
Transvenous implantation, which involves threading a device through blood vessels, combined with intracardiac echocardiography, is a viable option for these patients.
This approach is particularly beneficial for individuals with adult congenital heart disease.*
The study analyzed the safety and effectiveness of catheter ablation for tachyarrhythmias using data from Swedish national registries, focusing on over 26,000 patients from 2006 to 2015.* !
-
Key findings showed a rising incidence of ablation procedures for atrial fibrillation, ventricular tachycardia, and premature ventricular contractions, alongside a decrease in procedural times and fluoroscopy usage over the years.* !
-
Despite the complexity of the procedures increasing, the rate of adverse events remained low, and the efficacy, particularly for atrial fibrillation, showed improvement.* !